Mikko Hiltunen

P.O.Box 100, KYS
Kuopio, 70029, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 196 publications

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Journal: American journal of human genetics

Published: April 20, 2026

Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks.

Non-microglial downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease-related hallmarks.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insights.

Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insights.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insights.

Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insights.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Genetic architecture of Alzheimer's disease-related plasma biomarkers.

Genetic architecture of Alzheimer's disease-related plasma biomarkers.

Journal: Neurobiology of aging

Published: January 20, 2026

Biobank-based genetic characterization of neurodegenerative diseases and idiopathic normal pressure hydrocephalus: insights and lessons learned from FinnGen.

Biobank-based genetic characterization of neurodegenerative diseases and idiopathic normal pressure hydrocephalus: insights and lessons learned from FinnGen.

Journal: Molecular psychiatry

Published: January 18, 2026

Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals.

Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals.

Journal: Alzheimer's research & therapy

Published: November 14, 2025

Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models.

Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 31, 2025

Protective PLCG2 variants associate with a delayed onset of Alzheimer's disease among heterozygous APOE ε4 carriers.

Protective PLCG2 variants associate with a delayed onset of Alzheimer's disease among heterozygous APOE ε4 carriers.

Journal: Alzheimer's research & therapy

Published: October 07, 2025

Fibroblasts carrying intermediate C9orf72 hexanucleotide repeat expansions from iNPH patients show changes in energy metabolism but no cell pathologies.

Fibroblasts carrying intermediate C9orf72 hexanucleotide repeat expansions from iNPH patients show changes in energy metabolism but no cell pathologies.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: September 01, 2025

The proportion of Alzheimer's disease attributable to apolipoprotein E.

The proportion of Alzheimer's disease attributable to apolipoprotein E.

Journal: NPJ dementia

Published: August 27, 2025

Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer's Disease in European Populations: Development and Validation.

Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer's Disease in European Populations: Development and Validation.

Journal: medRxiv : the preprint server for health sciences

Published: August 06, 2025

Showing 1-12 of 196

Last Updated: 09/26/2026